BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 7830794)

  • 1. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
    Shivdasani RA; Mayer EL; Orkin SH
    Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
    Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
    Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
    Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
    Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny.
    Giroux S; Kaushik AL; Capron C; Jalil A; Kelaidi C; Sablitzky F; Dumenil D; Albagli O; Godin I
    Gene Expr Patterns; 2007 Jan; 7(3):215-26. PubMed ID: 17112790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene.
    Mikkola HK; Klintman J; Yang H; Hock H; Schlaeger TM; Fujiwara Y; Orkin SH
    Nature; 2003 Jan; 421(6922):547-51. PubMed ID: 12540851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCL and related hemopoietic helix-loop-helix transcription factors.
    Green AR; Begley CG
    Int J Cell Cloning; 1992 Sep; 10(5):269-76. PubMed ID: 1453013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation.
    Murrell AM; Bockamp EO; Göttgens B; Chan YS; Cross MA; Heyworth CM; Green AR
    Oncogene; 1995 Jul; 11(1):131-9. PubMed ID: 7624120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIM domain proteins in leukaemia and development.
    Sánchez-García I; Rabbitts TH
    Semin Cancer Biol; 1993 Dec; 4(6):349-58. PubMed ID: 8142620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pufferfish SLP-1 gene, a new member of the SCL/TAL-1 family of transcription factors.
    Göttgens B; Gilbert JG; Barton LM; Aparicio S; Hawker K; Mistry S; Vaudin M; King A; Bentley D; Elgar G; Green AR
    Genomics; 1998 Feb; 48(1):52-62. PubMed ID: 9503016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
    Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
    Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin immunoselection defines a TAL-1 target gene.
    Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
    EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
    Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
    J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
    Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
    Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
    Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
    EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
    Murrell AM; Green AR
    Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system.
    Visvader J; Begley CG; Adams JM
    Oncogene; 1991 Feb; 6(2):187-94. PubMed ID: 2000219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
    Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
    Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
    Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
    Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.
    Breit TM; Wolvers-Tettero IL; van Dongen JJ
    Oncogene; 1994 Jul; 9(7):1847-53. PubMed ID: 8208530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.